Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma
Ashujit Tagde(Dana-Farber Cancer Institute), Donald Küfe(Dana-Farber Cancer Institute)
Cited by 9
Related Papers
Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors
|Hybridoma|1984|580
A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.
|PubMed|2000|296
PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
|Journal of Immunotherapy|2011|285
Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily
|Journal of Clinical Oncology|2002|244
Triterpenoid CDDO-Me Blocks the NF-κB Pathway by Direct Inhibition of IKKβ on Cys-179
|Journal of Biological Chemistry|2006|232